WO2007049276A3 - Compositions for- detecting of influenza viruses and kits and methods using same - Google Patents

Compositions for- detecting of influenza viruses and kits and methods using same Download PDF

Info

Publication number
WO2007049276A3
WO2007049276A3 PCT/IL2006/001226 IL2006001226W WO2007049276A3 WO 2007049276 A3 WO2007049276 A3 WO 2007049276A3 IL 2006001226 W IL2006001226 W IL 2006001226W WO 2007049276 A3 WO2007049276 A3 WO 2007049276A3
Authority
WO
WIPO (PCT)
Prior art keywords
kits
same
compositions
detecting
methods
Prior art date
Application number
PCT/IL2006/001226
Other languages
French (fr)
Other versions
WO2007049276A2 (en
Inventor
Dorit Arad
Assaf Ezra
Original Assignee
Mnd Diagnostic Ltd
Dorit Arad
Assaf Ezra
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mnd Diagnostic Ltd, Dorit Arad, Assaf Ezra filed Critical Mnd Diagnostic Ltd
Priority to AU2006307458A priority Critical patent/AU2006307458A1/en
Priority to US12/091,665 priority patent/US20090220941A1/en
Priority to CA002627323A priority patent/CA2627323A1/en
Priority to EP06809787A priority patent/EP1954296A4/en
Priority to JP2008537311A priority patent/JP2009516502A/en
Publication of WO2007049276A2 publication Critical patent/WO2007049276A2/en
Priority to IL191024A priority patent/IL191024A0/en
Publication of WO2007049276A3 publication Critical patent/WO2007049276A3/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/739—Lipopolysaccharides
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56983—Viruses
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/005—Assays involving biological materials from specific organisms or of a specific nature from viruses
    • G01N2333/08—RNA viruses
    • G01N2333/11—Orthomyxoviridae, e.g. influenza virus
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2400/00—Assays, e.g. immunoassays or enzyme assays, involving carbohydrates
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Virology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Hematology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Urology & Nephrology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Analytical Chemistry (AREA)
  • Pathology (AREA)
  • Biotechnology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • General Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)

Abstract

An isolated composition-of-matter comprising a sialic acid bound to a sialic acid binding domain of a polypeptide is provided. Uses thereof and kits comprising same are also provided.
PCT/IL2006/001226 2005-10-25 2006-10-25 Compositions for- detecting of influenza viruses and kits and methods using same WO2007049276A2 (en)

Priority Applications (6)

Application Number Priority Date Filing Date Title
AU2006307458A AU2006307458A1 (en) 2005-10-25 2006-10-25 Compositions for- detecting of influenza viruses and kits and methods using same
US12/091,665 US20090220941A1 (en) 2005-10-25 2006-10-25 Compositions for- detecting of influenza viruses and kits and methods using same
CA002627323A CA2627323A1 (en) 2005-10-25 2006-10-25 Compositions for- detecting of influenza viruses and kits and methods using same
EP06809787A EP1954296A4 (en) 2005-10-25 2006-10-25 Compositions for- detecting of influenza viruses and kits and methods using same
JP2008537311A JP2009516502A (en) 2005-10-25 2006-10-25 Influenza virus detection composition and kit and methods of use thereof
IL191024A IL191024A0 (en) 2005-10-25 2008-04-27 Compositions for-detecting of influenza viruses and kits and methods using same

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US72975205P 2005-10-25 2005-10-25
US60/729,752 2005-10-25

Publications (2)

Publication Number Publication Date
WO2007049276A2 WO2007049276A2 (en) 2007-05-03
WO2007049276A3 true WO2007049276A3 (en) 2009-04-09

Family

ID=37968215

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/IL2006/001226 WO2007049276A2 (en) 2005-10-25 2006-10-25 Compositions for- detecting of influenza viruses and kits and methods using same

Country Status (8)

Country Link
US (1) US20090220941A1 (en)
EP (1) EP1954296A4 (en)
JP (1) JP2009516502A (en)
KR (1) KR20080083266A (en)
CN (1) CN101553581A (en)
AU (1) AU2006307458A1 (en)
CA (1) CA2627323A1 (en)
WO (1) WO2007049276A2 (en)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2011133450A2 (en) * 2010-04-19 2011-10-27 Meso Scale Technologies, Llc. Serology assays
US11268958B2 (en) 2012-09-14 2022-03-08 The Johns Hopkins University Bacteria-specific labeled substrtates as imaging biomarkers to diagnose, locate, and monitor infections
CN103543269B (en) * 2013-10-16 2015-07-22 北京华卫天和生物科技有限公司 Preparation method for quantum-dot-marked immunochromatographic test paper
CN103529216B (en) * 2013-10-16 2015-07-22 北京华卫骥生物医药有限公司 Preparation method for quantum-dot labeled immunochromatography test paper
CN103543262B (en) * 2013-10-16 2015-07-22 北京华卫天和生物科技有限公司 Method for detecting EB (Epstein-Barr) virus, quantum dot labelled immunochromatographic test strip and preparation method thereof
CN106771245B (en) * 2016-12-29 2019-03-12 上海鸣捷生物科技有限公司 H9 subtype avian influenza virus antigen conjugated magnetic particle and its preparation method and application
WO2019182466A1 (en) * 2018-03-21 2019-09-26 Общество с ограниченной ответственностью "Синтавр" Method for specific detection of an influenza virus in a person
KR102050213B1 (en) * 2018-10-02 2019-11-29 한국생명공학연구원 Probe system for rapid detecting influenza virus using biomolecular fluorescence complementation and rapid detection method of influenza virus using the same
KR102332656B1 (en) * 2018-11-05 2021-12-01 고려대학교 산학협력단 Recombinant Newcastle Disease Virus vector including H9 hemaglutinin and recombinant virus made therefrom
KR102434936B1 (en) * 2020-02-11 2022-08-22 충북대학교 산학협력단 Magnetic bead coated sialic acid and galactose complex for detecting or captureing influenza virus a and use thereof
CN115298548A (en) * 2020-03-17 2022-11-04 李知勋 Method for detecting viruses having hemagglutinin esterase activity

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999031280A1 (en) * 1997-12-18 1999-06-24 Sepracor Inc. Screening assays for the detection and diagnosis of influenza virus
US20050112751A1 (en) * 2002-11-22 2005-05-26 Fang Fang Novel class of therapeutic protein based molecules

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999031280A1 (en) * 1997-12-18 1999-06-24 Sepracor Inc. Screening assays for the detection and diagnosis of influenza virus
US20050112751A1 (en) * 2002-11-22 2005-05-26 Fang Fang Novel class of therapeutic protein based molecules

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See also references of EP1954296A4 *

Also Published As

Publication number Publication date
US20090220941A1 (en) 2009-09-03
CA2627323A1 (en) 2007-05-03
CN101553581A (en) 2009-10-07
AU2006307458A1 (en) 2007-05-03
WO2007049276A2 (en) 2007-05-03
JP2009516502A (en) 2009-04-23
EP1954296A2 (en) 2008-08-13
KR20080083266A (en) 2008-09-17
EP1954296A4 (en) 2010-09-15

Similar Documents

Publication Publication Date Title
WO2007049276A3 (en) Compositions for- detecting of influenza viruses and kits and methods using same
WO2006119107A3 (en) Sclerostin binding agents
WO2006119062A3 (en) Sclerostin epitopes
WO2008133722A3 (en) Anti human sclerostin antibodies
WO2006078645A3 (en) Heterologous polypeptide expression using low multiplicity of infection of viruses
EP2298308A3 (en) Integrin-binding small molecules
WO2007079218A3 (en) Metalloproteinase binding proteins
WO2006122188A3 (en) Tripeptides as hepatitis c virus inhibitors
WO2008008776A3 (en) Hepatitis c virus inhibitors
WO2007070538A9 (en) Anti-mn antibodies and methods of using same
WO2010029278A3 (en) Isolation and identification of glycosaminoglycans
EA200702278A1 (en) ANTIBODIES SPECIFIC FOR TGF-BETA 1
WO2008060927A3 (en) Hepatitis c virus inhibitors
WO2009111450A3 (en) Metalloproteinase 9 binding proteins
WO2009111508A3 (en) Metalloproteinase 9 and metalloproteinase 2 binding proteins
WO2007059513A3 (en) Compositions and methods for modulating hemostasis
WO2008097342A3 (en) Compositions and methods for isolation of biological molecules
WO2008070616A3 (en) METHODS AND COMPOSITIONS RELATED TO HIF-1α
WO2006087163A3 (en) Novel in vitro methods for studying receptors recognizing volatile compounds
WO2008033333A3 (en) Il-1 family variants
WO2006079057A3 (en) Methods and compositions for specific inhibition of protein splicing by small molecules
WO2007022321A3 (en) Substituted indoles and use thereof
WO2008073863A3 (en) Preparation and utility of substituted allylamines
WO2006116498A3 (en) Purified form of tanaproget
WO2009097397A3 (en) Metalloproteinase binding proteins

Legal Events

Date Code Title Description
WWE Wipo information: entry into national phase

Ref document number: 200680047215.2

Country of ref document: CN

121 Ep: the epo has been informed by wipo that ep was designated in this application
WWE Wipo information: entry into national phase

Ref document number: 2627323

Country of ref document: CA

ENP Entry into the national phase

Ref document number: 2008537311

Country of ref document: JP

Kind code of ref document: A

NENP Non-entry into the national phase

Ref country code: DE

WWE Wipo information: entry into national phase

Ref document number: 191024

Country of ref document: IL

WWE Wipo information: entry into national phase

Ref document number: 2293/CHENP/2008

Country of ref document: IN

WWE Wipo information: entry into national phase

Ref document number: 2006809787

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 2006307458

Country of ref document: AU

WWE Wipo information: entry into national phase

Ref document number: 1020087012495

Country of ref document: KR

ENP Entry into the national phase

Ref document number: 2006307458

Country of ref document: AU

Date of ref document: 20061025

Kind code of ref document: A

WWP Wipo information: published in national office

Ref document number: 2006307458

Country of ref document: AU

WWP Wipo information: published in national office

Ref document number: 2006809787

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 12091665

Country of ref document: US